Skip to main content
. 2017 Oct 6;7(10):e015112. doi: 10.1136/bmjopen-2016-015112

Table 2.

Number of cause-specific deaths, HRs for cause-specific death of CVD and its subtypes according to hs-CRP levels

Diagnosis at the emergency department Total hs-CRP levels (mg/L) p for trend (across categories) Continuous log scale p for
trend 
(continuous)
<3.0 3.1–5.4 5.5–11.5 11.6–33.2 ≥33.3
CVD
 No of patients 12 211 7375 1212 1200 1216 1208
 No of CVD deaths 976 484 106 116 120 150
 CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
1.16
(0.94 to 1.43)
1.23
(1.00 to 1.51)
1.20
(0.98 to 1.46)
1.44*
(1.20 to 1.73)
<0.001 1.08*
(1.03 to 1.11)
<0.001
 CVD-related,
 Age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
1.13
(0.92 to 1.40)
1.20
(1.00 to 1.48)
1.16
(0.95 to 1.42)
1.33*
(1.10 to 1.61)
0.002 1.05*
(1.01 to 1.09)
0.004
 No of non-CVD deaths 180 33 10 18 29 90
 Non-CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
1.55
(0.76 to 3.15)
2.67*
(1.50 to 4.75)
3.84*
(2.32 to 6.35)
12.05*
(8.05 to 18.04)
<0.001 1.77*
(1.63 to 1.93)
<0.001
 Non-CVD-related,
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
1.52
(0.75 to 3.09)
2.61*
(1.47 to 4.65)
3.72*
(2.25 to 6.16)
11.49*
(7.66 to 17.23)
<0.001 1.75*
(1.61 to 1.91)
<0.001
Acute myocardial infarction
 No of patients 1347 796 145 126 125 155
 No of CVD deaths 70 25 2 11 7 25
 CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
0.37
(0.09 to 1.56)
1.93
(0.94 to 3.95)
1.31
(0.56 to 3.05)
3.51*
(1.98 to 6.23)
<0.001 1.30*
(1.14 to 1.48)
<0.001
 CVD-related,
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
0.35
(0.08 to 1.47)
1.74
(0.85 to 3.58)
1.01
(0.41 to 2.47)
2.71*
(1.50 to 4.90)
0.001 1.23*
(1.08 to 1.40)
0.002
 No of non-CVD deaths 19 3 2 1 2 11
 Non-CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
2.82
(0.47 to 17.04)
1.21
(0.12 to 11.75)
2.59
(0.42 to 15.84)
10.14*
(2.75 to 37.33)
<0.001 1.73*
(1.32 to 2.28)
<0.001
 Non-CVD-related,
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
2.71
(0.45 to 16.45)
1.11
(0.11 to 10.81)
2.07
(0.31 to 13.72)
8.64*
(2.32 to 32.27)
0.001 1.67*
(1.27 to 2.21)
<0.001
Heart failure
 No of patients 1742 620 232 249 310 331
 No of CVD deaths 98 15 10 21 19 33
 CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
1.49
(0.67 to 3.33)
2.27
(1.14 to 4.51)
1.76
(0.88 to 3.48)
2.58*
(1.39 to 4.79)
0.004 1.23*
(1.09 to 1.39)
0.001
 CVD-related
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
1.49
(0.67 to 3.32)
2.29
(1.15 to 4.56)
1.78
(0.90 to 3.54)
2.66*
(1.42 to 4.97)
0.003 1.24*
(1.09 to 1.41)
0.001
 No of non-CVD deaths 50 4 1 7 10 28
 Age-adjusted and sex-adjusted HR (95% CI) 1
(ref.)
0.52
(0.06 to 4.68)
2.50
(0.72 to 8.74)
2.92
(0.91 to 9.42)
6.80*
(2.36 to 19.57)
<0.001 1.69*
(1.38 to 2.08)
<0.001
 Non-CVD-related,
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
0.51
(0.06 to 4.57)
2.52
(0.72 to 8.80)
3.21
(0.99 to 10.33)
8.19*
(2.82 to 23.80)
<0.001 1.84*
(1.47 to 2.29)
<0.001
Cerebral infarction
 No of patients 2879 1823 277 281 271 227
 No of CVD deaths 230 103 22 33 38 34
 CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
1.08
(0.68 to 1.72)
1.76
(1.19 to 2.61)
1.95*
(1.34 to 2.84)
2.13*
(1.44 to 3.14)
<0.001 1.21*
(1.12 to 1.30)
<0.001
 CVD-related
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
0.99
(0.62 to 1.57)
1.59
(1.07 to 2.35)
1.48
(1.00 to 2.19)
1.44
(0.95 to 2.20)
0.012 1.11
(1.03 to 1.21)
0.008
 No of non-CVD deaths 31 6 3 1 5 16
 Non-CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
2.07
(0.51 to 8.41)
0.92
(0.11 to 7.63)
3.08
(0.91 to 10.49)
18.78*
(7.27 to 48.51)
<0.001 1.95*
(1.57 to 2.41)
<0.001
 Non-CVD-related
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
2.20
(0.54 to 8.99)
0.99
(0.12 to 8.29)
3.87
(1.10 to 13.62)
24.08*
(8.62 to 67.25)
<0.001 2.08*
(1.65 to 2.64)
<0.001
Intracerebral haemorrhage
 No of patients 1989 1428 167 153 137 104
 No of CVD deaths 313 196 37 29 28 23
 CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
1.56
(1.10 to 2.22)
1.25
(0.84 to 1.84)
1.32
(0.88 to 1.97)
1.49
(0.96 to 2.30)
0.019 1.07
(1.00 to 1.14)
0.061
 CVD-related,
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
1.52
(1.07 to 2.17)
1.23
(0.83 to 1.82)
1.29
(0.86 to 1.92)
1.30
(0.82 to 2.04)
0.020 1.05
(0.98 to 1.13)
0.166
 No of non-CVD deaths 25 5 2 3 1 14
 Non-CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
3.17
(0.62 to 16.37)
5.13
(1.22 to 21.58)
1.85
(0.21 to 16.09)
32.57*
(11.41 to 92.97)
<0.001 2.26*
(1.78 to 2.86)
<0.001
 Non-CVD-related
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
3.05
(0.59 to 15.77)
4.97
(1.18 to 20.89)
1.77
(0.20 to 15.38)
28.22*
(9.76 to 81.58)
<0.001 2.21*
(1.73 to 2.81)
<0.001
Others
 No of patients 4254 2708 391 391 373 391
 No of CVD deaths 265 145 35 22 28 35
 CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
1.45
(1.00 to 2.11)
0.83
(0.53 to 1.30)
1.02
(0.67 to 1.54)
1.01
(0.67 to 1.54)
0.894 1.01
(0.95 to 1.08)
0.750
 CVD-related
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
1.32
(0.91 to 1.91)
0.57
(0.35 to 0.93)
0.77
(0.53 to 1.14)
1.03
(1.02 to 1.04)
0.119 0.96
(0.90 to 1.03)
0.212
 No of non-CVD deaths 55 15 2 6 11 21
 Non-CVD-related
 age-adjusted and sex-adjusted HR (95% CI)
1
(ref.)
0.86
(0.20 to 3.76)
2.08
(0.80 to 5.40)
3.62*
(1.63 to 8.05)
4.87*
(2.47 to 9.61)
<0.001 1.44*
(1.25 to 1.65)
<0.001
 Non-CVD-related
 age-adjusted, sex-adjusted and WCC-adjusted HR (95% CI)
1
(ref.)
0.90
(0.21 to 3.93)
2.24
(0.86 to 5.85)
3.87*
(1.73 to 8.64)
5.30*
(2.66 to 10.54)
<0.001 1.47*
(1.28 to 1.69)
<0.001

*Statistically significant after applying a Bonferroni correction.

Acute myocardial infarction: ICD-10 (I21–I24); cerebral infarction: ICD-10 (I63); CVD: International Statistical Classification of Diseases and related problems 10th revision (below ICD-10) Diseases of the circulatory system (I00-I99); heart failure: ICD-10 (I50); intracerebral haemorrhage: ICD-10 (I61).

CVD, cardiovascular disease; hs-CRP, high-sensitivity C reactive protein; WCC, white cell count.